Track record · closed signal

Ecovyst Inc (ECVT) — closed signal from May 25, 2026

Partial Published before the outcome was known, scored automatically when the window closed on August 23, 2026 — -24.4% at the close.

Predicted vs. what happened

ECVT price · publication thesis → realized outcomesplit-adjusted
$13.81 Published $15.19 Target $10.44 Window close $14.14 Peak
$13.20 – $13.90Entry zone — fair-value band
$13.81Published — price the day we called it
$15.19Target — the price the thesis aimed for
$14.14Peak — highest point inside the window, not a realized return
$10.44Window close — end-of-window price, context only

What happened

Partial

Reached 24% of the predicted growth at its peak, without hitting the target.

At window close
-24.4%
realized, from the publication price to the last close inside the window
Peak gain
+2.4%
peak, from the publication price — not a realized return
S&P 500, same window
+3%
SPY over the identical days, dividend-adjusted
Window close
$10.44
last close inside the window, ended August 23, 2026
Peak price
$14.14
peak on May 26, 2026 — not a realized return
Days to target
—

The thesis — published May 25, 2026

Predicted growth
+10%
over the measurement window
Target price
$15.19
the price the thesis aimed for
Entry zone
$13.20 – $13.90
the fair-value band we waited for
Price at publication
$13.81
published May 25, 2026
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Ecovyst shows signs of a potential recovery: sales are improving, cash on hand is solid, and a recent acquisition could make future earnings clearer. The company noted Q1 earnings and a planned Calabrian deal that could speed a turnaround. However, losses, low trading activity and weak price momentum limit conviction; this is a watch-list setup over the next 0-3 months.

Primary drivers

  • The Calabrian deal could expand the company into more specialty products
  • Recent quarterly update gives clearer signs that earnings may recover
  • Strong cash and liquidity reduce integration risk for the acquisition
  • Demand for industrial catalysts helps diversify revenue sources

How it played out

ECVT: the 10% thesis did not play out

Lyra published ECVT at $13.81 with an expected 10% rise to $15.19. The thesis pointed to improving sales, solid cash and liquidity, the planned Calabrian acquisition, a clearer earnings picture after the Q1 update, and demand for industrial catalysts. It also noted losses, low trading activity, and weak price momentum.

The price peaked at $14.14 on May 26, a 2.4% gain. It never reached the $15.19 target. By August 23, it had fallen to $10.44. The published thesis missed within the measurement window.

What happened during the window

On June 30, Ecovyst completed its acquisition of Calabrian. On August 5, the company reported second-quarter sales growth of 42% to $250.0 million and raised its 2026 outlook.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.